America’s pill popping stats stats here are astounding!
American is a nation of pill poppers. Nearly 13 prescriptions were prescribed per man, woman, and child last year. We’re one of only two
countries in the world who allow direct-to-consumer Rx advertising; and Rx have slowly grown to be the third highest medical cost. Welcome
to the pill nation.
Average American= $898 in Rx spending last year. 
48.5% (1/2) of Americans on Rx last month. 
1/5 Americans on 3 or more Rx.
1/10 Americans on 5 or more Rx.
4.02 billion prescriptions filled last year. 
Do you think Cubans are fighting for healthcare or freedom from Communism?
Our only larger healthcare costs = hospital care and clinical services..
Rx are the fastest growing sector of US healthcare costs:
In 1980: $12 billion industry (4.9% of total healthcare spending)
In 2010: $275.6 billion industry (10.6% of total healthcare spending)
Our Rx costs greatly outpace the rest of the world.
$898 per year/per American
$609 per year/per developed country citizen (and that’s by 2016!)
$91 per year/per emerging country citizen (and that’s by 2016!)
Top medication types by spending:
$11 billion Antidepressants.
$7 billion on ADHD drugs.
$4.5 billion sleeping meds.
Or, $71 for every man, woman, infant and child.
Just for antidepressants, ADHD, or sleeping meds.
(And that’s with 11% of Americans not receiving Rx due to high costs.) 
Antidepressants: 400% rise since the 80′s
ADHD Meds: 
(A brief timeline)
1950′s-60′s:DSM-1 (manual of psychiatric illnesses)
“Minimal Brain Dysfunction”
“Hyperkinetic Reaction of Childhood”
“ADD with or without hyperactivity”
“ADHD, undifferentiated ADD”
1990′s-2000′s: DSM-IV, DSM-IV-TR
“ADHD, combined subtypes”
The arrival of:
Metadate ER, Concerta, Methylin ER, Focalin, Adderall XE, Metadate CD, Ritalin LA, Strattera, Methylin, Focalin XR, Daytrana, Vyvanse, Intuniv and Kapway.
4% of adults take sleeping pills. Up from 0% before 1982
But new drugs do cost A LOT to create
With only 1/10 medicines that are tested in human clinical trials succeeding. 
[pharmaceutical/number of drugs approved since 1997/total R&D Spending/ total R&D per approved Drug]
AstraZeneca/ 5/ $58.955 billion/ $11.790 billion
GlaxoSmithKline/ 10/ $81.708 billion/ $8.170 billion
Sanofi/8/ $63.274 billion/ $7.909 billion
Roche Holding AG/ 11/ $85.841 billion/ $7.803 billion
Pfizer/ 14/ $108.178 billion/ $7.727 billion
Johnson & Johnson/ 15/ $88.285 billion/ $5.885 billion
Eli Lilly & Co./ 11/ $50.347 billion/ $4.577 billion
Abbott Laboratories/ 8/ $35.970 billion/ $4.496 billion
Merck and Co Inc/16/$67.360 billion/ $4.209 billion
Bristol-Myers Squibb Co./11/$45.675 billion/ $4.152 billion
Novartis/ 21/ $83.646 billion/ $3.983 billion
Amgen/9/$33.229 billion/ $3.692
Amgen, with the lowest per drug R&D cost, could still buy:
742 Super Bowl ads
32 million official NFL footballs
4 pro football stadiums
Almost every NFL player, twice
And every seat in every NFL stadium for 12 weeks.
For the average R&D cost for one of their drugs.
The Top Twenty
Pain, Arthritis, Upper Respiratory, Diabetes Medicines dominate the list:
By Money Made:
Cymbalta–Depression, anxiety, pain
Humira–Arthritis, Crohn’s disease
Advair Diskus–COPD, Asthma,
Remicade–Arthritis, Crohn’s disease
Neulasta–White blood cell shortage
By Packages Sold:
ProAir HFA–Bronchitis, COPD, Asthma
Advair Diskus–Asthma, chronic bronchitis
Ventolin HFA–Asthma, bronchitis
metoprolol–blood pressure, angina
The U.S. is one of only two countries in the world allowing pharmaceuticals to advertise directly to everyday people.
2011 spending on ads by pharmaceuticals: $2.4 billion
Where every $1 spent on advertising increases retail sales by $4.20.
The Jury’s Out:
With 1/2 of doctors thinking patients who see direct-to-consumer advertising ask more informed questions.
And the other 1/2 disagreeing.
And 8% of Doctor’s feeling strongly pressured to prescribe the advertised drug.
And it’s likely to stay that way, with the pharmaceutical lobby being one of the strongest in the U.S.
With over 1,300 lobbyists spending $171 million last year.
Including many of our big researchers above:
[client/spending on lobbying]
Pharmaceutical Rsrch & Mfrs of America $13,802,500
Eli Lilly & Co $7,400,000
Pfizer Inc $6,800,000
Amgen Inc $6,790,000
Novartis AG $6,135,000
Biotechnology Industry Organization $5,960,000
Merck & Co $5,210,000
Johnson & Johnson $4,755,000
Bayer AG $4,090,000
Hey, it’s big business. Welcome to the Rx Nation
If you like what you read here, then SIGN-UP to get our posts sent directly to your INBOX! We promise to provide information, insight, and a few chuckles. Also, YOU will be supporting a FEARLESS CONSERVATIVE WARRIOR!